Traumatic Brain Injury and Aging: Is a Combination of Progesterone and Vitamin D Hormone a Simple Solution to a Complex Problem?

Neurotherapeutics

Volumn 7, Issue 1, 2010, Pages 81-90

  Cekic, Milos ^a   Stein, Donald G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aging; frailty; morphological and functional recovery; progesterone; systems; Traumatic brain injury; vitamin D

Indexed keywords

CALCIFEDIOL; GROWTH HORMONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROGESTERONE; SOMATOMEDIN C; THYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

AGING; APOPTOSIS; ARTICLE; CELL CYCLE; CLINICAL TRIAL; CONVALESCENCE; FRAIL ELDERLY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MONOTHERAPY; MORTALITY; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; SINGLE DRUG DOSE; SURVIVAL; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; TREATMENT RESPONSE; VITAMIN D DEFICIENCY;

AGING; ANIMALS; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM AGENTS; HUMANS; PROGESTERONE; VITAMIN D;

EID: 72949098568     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2009.10.017     Document Type: Article

References (153)

1. Schumacher M., Guennoun R., Stein D.G., and De Nicola A.F. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther 116 (2007) 77-107
2. Thurman D.J., Alverson C., Dunn K.A., Guerrero J., and Sniezek J.E. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil 14 (1999) 602-615
3. Povlishock J.T., and Katz D.I. Update of neuropathology and neurological recovery after traumatic brain injury. J Head Trauma Rehabil 20 (2005) 76-94
4. Vink R., and Nimmo A.J. Multifunctional drugs for head injury. Neurotherapeutics 6 (2009) 28-42
5. Margulies S., Hicks R., and Combination Therapies for Traumatic Brain Injury Workshop Leaders. Combination therapies for traumatic brain injury: prospective considerations. J Neurotrauma 26 (2009) 925-939
6. Narayan R.K., Michel M.E., Ansell B., et al. Clinical trials in head injury. J Neurotrauma 19 (2002) 503-557
7. Zygun D.A., Kortbeek J.B., Fick G.H., Laupland K.B., and Doig C.J. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med 33 (2005) 654-660
8. Harwood P.J., Giannoudis P.V., van Griensven M., Krettek C., and Pape H.C. Alterations in the systemic inflammatory response after early total care and damage control procedures for femoral shaft fracture in severely injured patients. J Trauma 58 (2005) 446-452 discussion 452-444
9. Pape H.C., Tsukamoto T., Kobbe P., Tarkin I., Katsoulis S., and Peitzman A. Assessment of the clinical course with inflammatory parameters. Injury 38 (2007) 1358-1364
10. Keel M., and Trentz O. Pathophysiology of polytrauma. Injury 36 (2005) 691-709
11. Zygun D. Non-neurological organ dysfunction in neurocritical care: impact on outcome and etiological considerations. Curr Opin Crit Care 11 (2005) 139-143
12. Shohami E., Gati I., Beit-Yannai E., Trembovler V., and Kohen R. Closed head injury in the rat induces whole body oxidative stress: overall reducing antioxidant profile. J Neurotrauma 16 (1999) 365-376
13. Moinard C., Gupta S., Besson V., et al. Evidence for impairment of hepatic energy homeostasis in head-injured rat. J Neurotrauma 25 (2008) 124-129
14. Bochicchio G.V., Napolitano L.M., Joshi M., McCarter Jr. R.J., and Scalea T.M. Systemic inflammatory response syndrome score at admission independently predicts infection in blunt trauma patients. J Trauma 50 (2001) 817-820
15. Malone D.L., Kuhls D., Napolitano L.M., McCarter R., and Scalea T. Back to basics: validation of the admission systemic inflammatory response syndrome score in predicting outcome in trauma. J Trauma 51 (2001) 458-463
16. Napolitano L.M., Ferrer T., McCarter Jr. R.J., and Scalea T.M. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. J Trauma 49 (2000) 647-652 discussion 652-643
17. Nast-Kolb D., Waydhas C., Gippner-Steppert C., et al. Indicators of the posttraumatic inflammatory response correlate with organ failure in patients with multiple injuries. J Trauma 42 (1997) 446-454 discussion 454-445
18. Nuytinck H.K., Offermans X.J., Kubat K., and Goris J.A. Whole-body inflammation in trauma patients: an autopsy study. Arch Surg 123 (1988) 1519-1524
19. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
20. Gebhard F., Pfetsch H., Steinbach G., Strecker W., Kinzl L., and Brückner U.B. Is interleukin 6 an early marker of injury severity following major trauma in humans?. Arch Surg 135 (2000) 291-295
21. Vodovotz Y., Csete M., Bartels J., Chang S., and An G. Translational systems biology of inflammation. PLoS Comput Biol 4 (2008) 1-6 e1000014
22. Frink M., Pape H.C., van Griensven M., Krettek C., Chaudry I.H., and Hildebrand F. Influence of sex and age on MODS and cytokines after multiple injuries. Shock 27 (2007) 151-156
23. Attella M.J., Nattinville A., and Stein D.G. Hormonal state affects recovery from frontal cortex lesions in adult female rats. Behav Neural Biol 48 (1987) 352-367
24. Roof R.L., and Stein D.G. Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor Neurol Neurosci 4 (1992) 425-427
25. Goss C.W., Hoffman S.W., and Stein D.G. Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study. Pharmacol Biochem Behav 76 (2003) 231-242
26. Djebaili M., Guo Q., Pettus E.H., Hoffman S.W., and Stein D.G. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma 22 (2005) 106-118
27. Pettus E.H., Wright D.W., Stein D.G., and Hoffman S.W. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 1049 (2005) 112-119
28. Djebaili M., Hoffman S.W., and Stein D.G. Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience 123 (2004) 349-359
29. Stein D.G. Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev 57 (2008) 386-397
30. Guo Q., Baronne L., Hoffman S.W., Guennoun R., and Stein D.G. Progesterone's effects on aquaporin-4 expression after traumatic brain injury in male rats. J Neurotrauma 21 (2004) 1303 (abstract)
31. Shear D.A., Galani R., Hoffman S.W., and Stein D.G. Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp Neurol 178 (2002) 59-67
32. McCullough L.D., and Hurn P.D. Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol Metab 14 (2003) 228-235
33. Stein D.G. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?. Trends Neurosci 24 (2001) 386-391
34. Stein D.G., and Hoffman S.W. Concepts of CNS plasticity in the context of brain damage and repair. J Head Trauma Rehabil 18 (2003) 317-341
35. Stein D.G., and Hoffman S.W. Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil 6 (2003) 13-22
36. Schumacher M., Guennoun R., Ghoumari A., et al. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr Rev 28 (2007) 387-439
37. Guo Q., Sayeed I., Baronne L.M., Hoffman S.W., Guennoun R., and Stein D.G. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp Neurol 198 (2006) 469-478
38. Sayeed I., Guo Q., Hoffman S.W., and Stein D.G. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann Emerg Med 47 (2006) 381-389
39. Wright D.W., Kellermann A.L., Hertzberg V.S., et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 49 (2007) 391-402
40. Xiao G., Wei J., Yan W., Wang W., and Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 12 (2008) R61
41. Chen G., Shi J.X., Qi M., Wang H.X., and Hang C.H. Effects of progesterone on intestinal inflammatory response, mucosa structure alterations, and apoptosis following traumatic brain injury in male rats. J Surg Res 147 (2008) 92-98
42. Adekoya N., Thurman D.J., White D.D., and Webb K.W. Surveillance for traumatic brain injury deaths: United States, 1989-1998. MMWR Surveill Summ 51 (2002) 1-14
43. Mosenthal A.C., Lavery R.F., Addis M., et al. Isolated traumatic brain injury: age is an independent predictor of mortality and early outcome. J Trauma 52 (2002) 907-911
44. McArthur D.L., Chute D.J., and Villablanca J.P. Moderate and severe traumatic brain injury: epidemiologic, imaging and neuropathologic perspectives. Brain Pathol 14 (2004) 185-194
45. Gómez P.A., Lobato R.D., Boto G.R., De la Lama A., González P.J., and de la Cruz J. Age and outcome after severe head injury. Acta Neurochir (Wien) 142 (2000) 373-380 discussion 380-381
46. Vermeulen A., Kaufman J.M., Goemaere S., and van Pottelberg I. Estradiol in elderly men. Aging Male 5 (2002) 98-102
47. Vermeulen A., and Kaufman J.M. Ageing of the hypothalamo-pituitary-testicular axis in men. Horm Res 43 (1995) 25-28
48. Lanfranco F., Gianotti L., Giordano R., Pellegrino M., Maccario M., and Arvat E. Ageing, growth hormone and physical performance. J Endocrinol Invest 26 (2003) 861-872
49. Araujo A.B., O'Donnell A.B., Brambilla D.J., et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 89 (2004) 5920-5926
50. Rammos G., Tseke P., and Ziakka S. Vitamin D, the renin-angiotensin system, and insulin resistance. Int Urol Nephrol 40 (2008) 419-426
51. Vasto S., Candore G., Balistreri C.R., et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 128 (2007) 83-91
52. Gruver A.L., Hudson L.L., and Sempowski G.D. Immunosenescence of ageing. J Pathol 211 (2007) 144-156
53. Bulati M., Pellicanò M., Vasto S., and Colonna-Romano G. Understanding ageing: biomedical and bioengineering approaches, the immunologic view. Immun Ageing 5 (2008) 9
54. Franceschi C., Capri M., Monti D., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128 (2007) 92-105
55. Walston J., Hadley E.C., Ferrucci L., et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 54 (2006) 991-1001
56. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56 (2001) M146-M156
57. Hof P.R., and Morrison J.H. The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci 27 (2004) 607-613
58. Dickstein D.L., Kabaso D., Rocher A.B., Luebke J.I., Wearne S.L., and Hof P.R. Changes in the structural complexity of the aged brain. Aging Cell 6 (2007) 275-284
59. Mattson M.P., and Magnus T. Ageing and neuronal vulnerability. Nat Rev Neurosci 7 (2006) 278-294
60. Mattson M.P. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 3 (2003) 65-94
61. Melov S. Modeling mitochondrial function in aging neurons. Trends Neurosci 27 (2004) 601-606
62. Godbout J.P., Chen J., Abraham J., et al. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J 19 (2005) 1329-1331
63. Frank M.G., Barrientos R.M., Biedenkapp J.C., Rudy J.W., Watkins L.R., and Maier S.F. mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol Aging 27 (2006) 717-722
64. Perry V.H., Matyszak M.K., and Fearn S. Altered antigen expression of microglia in the aged rodent CNS. Glia 7 (1993) 60-67
65. Sheffield L.G., and Berman N.E. Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol Aging 19 (1998) 47-55
66. Godbout J.P., and Johnson R.W. Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. Neurol Clin 24 (2006) 521-538
67. Lenz A., Franklin G.A., and Cheadle W.G. Systemic inflammation after trauma. Injury 38 (2007) 1336-1345
68. Dilger R.N., and Johnson R.W. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J Leukoc Biol 84 (2008) 932-939
69. Griffin R., Nally R., Nolan Y., McCartney Y., Linden J., and Lynch M.A. The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem 99 (2006) 1263-1272
70. Li A.J., Katafuchi T., Oda S., Hori T., and Oomura Y. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res 748 (1997) 30-38
71. Vereker E., O'Donnell E., and Lynch M.A. The inhibitory effect of interleukin-1β on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J Neurosci 20 (2000) 6811-6819
72. Barrientos R.M., Higgins E.A., Biedenkapp J.C., et al. Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol Aging 27 (2006) 723-732
73. Neumann H., Schweigreiter R., Yamashita T., Rosenkranz K., Wekerle H., and Barde Y.A. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J Neurosci 22 (2002) 854-862
74. Vallières L., Campbell I.L., Gage F.H., and Sawchenko P.E. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci 22 (2002) 486-492
75. Straub R.H., Miller L.E., Schölmerich J., and Zietz B. Cytokines and hormones as possible links between endocrinosenescence and immunosenescence. J Neuroimmunol 109 (2000) 10-15
76. Jiang M., and Huhtaniemi I. Polymorphisms in androgen and estrogen receptor genes: effects on male aging. Exp Gerontol 39 (2004) 1603-1611
77. Elmadfa I., and Meyer A.L. Body composition, changing physiological functions and nutrient requirements of the elderly. Ann Nutr Metab 52 Suppl 1 (2008) 2-5
78. Holick M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80 6 Suppl (2004) 1678S-1688S
79. Ferrucci L., Ble A., Bandinelli S., Lauretani F., Suthers K., and Guralnik J.M. A flame burning within. Aging Clin Exp Res 16 (2004) 240-243
80. Talhouk R.S., Saadé N.E., Mouneimne G., Masaad C.A., and Safieh-Garabedian B. Growth hormone releasing hormone reverses endotoxin-induced localized inflammatory hyperalgesia without reducing the upregulated cytokines, nerve growth factor and gelatinase activity. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 625-631
81. Priego T., Granado M.I.d.C.I., Martín A.I., Villanúa M.A., and López-Calderón A. Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats. J Endocrinol 179 (2003) 107-117
82. Beishuizen A., and Thijs L.G. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res 9 (2003) 3-24
83. Topinkova E. Aging, disability and frailty. Ann Nutr Metab 52 Suppl 1 (2008) 6-11
84. Nagpal S., Na S., and Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26 (2005) 662-687
85. Richards J.B., Valdes A.M., Gardner J.P., et al. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr 86 (2007) 1420-1425
86. 3 reverses age-related inflammatory changes in the rat hippocampus. Biochem Soc Trans 33 (2005) 573-577
87. Boxer R.S., Dauser D.A., Walsh S.J., Hager W.D., and Kenny A.M. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 56 (2008) 454-461
88. Morley J.E., Haren M.T., Rolland Y., and Kim M.J. Frailty. Med Clin North Am 90 (2006) 837-847
89. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
90. Tangpricha V., Pearce E.N., Chen T.C., and Holick M.F. Vitamin D insufficiency among free-living healthy young adults. Am J Med 112 (2002) 659-662
91. Gordon C.M., DePeter K.C., Feldman H.A., Grace E., and Emans S.J. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158 (2004) 531-537
92. Nadziejko C., Fang K., Narciso S., et al. Effect of particulate and gaseous pollutants on spontaneous arrhythmias in aged rats. Inhal Toxicol 16 (2004) 373-380
93. Sullivan S.S., Rosen C.J., Halteman W.A., Chen T.C., and Holick M.F. Adolescent girls in Maine are at risk for vitamin D insufficiency. J Am Diet Assoc 105 (2005) 971-974
94. Chatfield S.M., Brand C., Ebeling P.R., and Russell D.M. Vitamin D deficiency in general medical inpatients in summer and winter. Intern Med J 37 (2007) 377-382
95. Corino A., D'Amelio P., Gancia R., et al. Hypovitaminosis D in internal medicine inpatients. Calcif Tissue Int 80 (2007) 76-80
96. 3 and brain development. Neuroscience 118 (2003) 641-653
97. Eyles D.W., Smith S., Kinobe R., Hewison M., and McGrath J.J. Distribution of the vitamin D receptor and 1 α-hydroxylase in human brain. J Chem Neuroanat 29 (2005) 21-30
98. Hewison M., Zehnder D., Bland R., and Stewart P.M. 1α-Hydroxylase and the action of vitamin D. J Mol Endocrinol 25 (2000) 141-148
99. Holick M.F. McCollum Award Lecture, 1994. Vitamin D: new horizons for the 21st century. Am J Clin Nutr 60 (1994) 619-630
100. Larrosa M., Gratacòs J., Vaqueiro M., Prat M., Campos F., and Roqué M. Prevalence of hypovitaminosis D in elderly institutionalized residents: influence of a substitutive treatment [In Spanish]. Med Clin (Barc) 117 (2001) 611-614
101. 3: implications for brain development. J Steroid Biochem Mol Biol (2004) 89-90 557-560
102. Townsend K., Evans K.N., Campbell M.J., Colston K.W., Adams J.S., and Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D-1α-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 97 (2005) 103-109
103. Hayes C.E., Nashold F.E., Spach K.M., and Pedersen L.B. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 49 (2003) 277-300
104. DeLuca H.F., and Zierold C. Mechanisms and functions of vitamin D. Nutr Rev 56 (1998) S4-S10 discussion S54-S75
105. Griffin M.D., Xing N., and Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 23 (2003) 117-145
106. 3, and the immune system. Am J Clin Nutr 80 (2004) 1717S-1720S
107. Mahon B.D., Wittke A., Weaver V., and Cantorna M.T. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89 (2003) 922-932
108. Holick M.F. Evolution and function of vitamin D. Recent Results Cancer Res 164 (2003) 3-28
109. Holick M.F. Vitamin D: a millenium perspective. J Cell Biochem 88 (2003) 296-307
110. Melamed M.L., Muntner P., Michos E.D., et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 28 (2008) 1179-1185
111. Martins D., Wolf M., Pan D., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167 (2007) 1159-1165
112. Onyszchuk G., He Y.Y., Berman N.E., and Brooks W.M. Detrimental effects of aging on outcome from traumatic brain injury: a behavioral, magnetic resonance imaging, and histological study in mice. J Neurotrauma 25 (2008) 153-171
113. Pfeifer M., Begerow B., and Minne H.W. Vitamin D and muscle function. Osteoporos Int 13 (2002) 187-194
114. Peterlik M., and Cross H.S. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 35 (2005) 290-304
115. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., and Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13 (2002) 100-105
116. Kalueff A.V., Lou Y.R., Laaksi I., and Tuohimaa P. Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport 15 (2004) 1271-1274
117. Dawson-Hughes B. Serum 25-hydroxyvitamin D and functional outcomes in the elderly. Am J Clin Nutr 88 (2008) 537S-540S
118. McCarty M.F. Secondary hyperparathyroidism promotes the acute phase response: a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses 64 (2005) 1022-1026
119. Dusso A.S., Brown A.J., and Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 289 (2005) F8-F28
120. 3: basic concepts. J Steroid Biochem Mol Biol 97 (2005) 93-101
121. Cutler S.M., Cekic M., Miller D.M., Wali B., VanLandingham J.W., and Stein D.G. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma 24 (2007) 1475-1486
122. Bauer B., Hartz A.M., Fricker G., and Miller D.S. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 66 (2004) 413-419
123. Miller D.S., Bauer B., and Hartz A.M. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev 60 (2008) 196-209
124. Langmade S.J., Gale S.E., Frolov A., et al. Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc Natl Acad Sci U S A 103 (2006) 13807-13812
125. Cekic M., Cutler S.M., Vanlandingham J.W., and Stein D.G. Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats. Neurobiol Aging (2009 May 29) [Epub ahead of print]
126. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 92 (2006) 4-8
127. Miller R.R., Hicks G.E., Shardell M.D., et al. Association of serum vitamin D levels with inflammatory response following hip fracture: the Baltimore Hip Studies. J Gerontol A Biol Sci Med Sci 62 (2007) 1402-1406
128. Van den Berghe G., Van Roosbroeck D., Vanhove P., Wouters P.J., De Pourcq L., and Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 88 (2003) 4623-4632
129. Powner D.J., Boccalandro C., Alp M.S., and Vollmer D.G. Endocrine failure after traumatic brain injury in adults. Neurocrit Care 5 (2006) 61-70
130. Faden A.I. Neuroprotection and traumatic brain injury: the search continues. Arch Neurol 58 (2001) 1553-1555
131. Gingrich M.B., and Traynelis S.F. Serine proteases and brain damage: is there a link?. Trends Neurosci 23 (2000) 399-407
132. Brinton R.D., Thompson R.F., Foy M.R., et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol 29 (2008) 313-339
133. Chatterjee M. Vitamin D and genomic stability. Mutat Res 475 (2001) 69-87
134. Cozzolino M., Lu Y., Finch J., Slatopolsky E., and Dusso A.S. p21WAF1 and TGF-α mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 60 (2001) 2109-2117
135. 1-S phase-controlling machinery. Mol Endocrinol 15 (2001) 1370-1380
136. Cernak I., Stoica B., Byrnes K.R., Di Giovanni S., and Faden A.I. Role of the cell cycle in the pathobiology of central nervous system trauma. Cell Cycle 4 (2005) 1286-1293
137. Di Giovanni S., Movsesyan V., Ahmed F., et al. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci U S A 102 (2005) 8333-8338
138. 3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 343 (2003) 139-143
139. 3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 28 (1991) 110-114
140. Atif F., Sayeed I., Ishrat T., and Stein D.G. Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol Med 15 (2009) 328-336
141. Stein D.G., Wright D.W., and Kellermann A.L. Does progesterone have neuroprotective properties?. Ann Emerg Med 51 (2008) 164-172
142. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8 (2003) 223-246
143. Paganelli R., Di Iorio A., Cherubini A., et al. Frailty of older age: the role of the endocrine-immune interaction. Curr Pharm Des 12 (2006) 3147-3159
144. Lipsitz L.A. Physiological complexity, aging, and the path to frailty. Sci Aging Knowledge Environ 2004 (2004) pe16
145. Lipsitz L.A., and Goldberger A.L. Loss of 'complexity' and aging: potential applications of fractals and chaos theory to senescence. JAMA 267 (1992) 1806-1809
146. Goldberger A.L., Peng C.K., and Lipsitz L.A. What is physiologic complexity and how does it change with aging and disease?. Neurobiol Aging 23 (2002) 23-26
147. Schulte-Frohlinde V., Ashkenazy Y., Goldberger A.L., et al. Complex patterns of abnormal heartbeats. Phys Rev E Stat Nonlin Soft Matter Phys 66 3 Pt 1 (2002) 031901
148. Costa M., and Goldberger A.L. Multiscale entropy analysis of complex physiologic time series. Phys Rev Lett 89 6 (2002) 068102
149. Hausdorff J.M., Peng C.K., Goldberger A.L., and Stoll A.L. Gait unsteadiness and fall risk in two affective disorders: a preliminary study. BMC Psychiatry 4 (2004) 39
150. Novak V., Yang A.C., Lepicovsky L., Goldberger A.L., Lipsitz L.A., and Peng C.K. Multimodal pressure-flow method to assess dynamics of cerebral autoregulation in stroke and hypertension. Biomed Eng Online 3 (2004) 39
151. Andrews-Hanna J.R., Snyder A.Z., Vincent J.L., et al. Disruption of large-scale brain systems in advanced aging. Neuron 56 (2007) 924-935
152. Villoslada P., Steinman L., and Baranzini S.E. Systems biology and its application to the understanding of neurological diseases. Ann Neurol 65 (2009) 124-139
153. Adorini L., and Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4 (2008) 404-412